In the presence of glioma cells, this CD8+ T cell subset appears to facilitate the enhancement of effector molecules, including CD45RA+CCR7−, T-bet+, CD107a+, IFN-γ+, and granzyme B+. This evidence concerns the gene CCR7 and central nervous system cancer.